| About the author: |
O. M. Ignatiev, O. I. Paniuta, T. L. Prutiian |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The purpose of the study was to assess the effect of loop diuretic therapy on the structural and functional condition of bone tissue and phosphorus-calcium metabolism in patients with chronic heart failure and moderately reduced ejection fraction. 109 patients between the ages of 65 and 74 were examined, 86 of them had chronic heart failure, and 23 were practically healthy. The 1st group received basic therapy; the 2nd group – basic therapy and loop diuretics. The examination includes the following: the collection of anamneses, anthropometric measurements, laboratory (determination of natriuretic hormone (B-type), N-terminal polypeptide, C-terminal telopeptide, osteocalcin, osteoprotegerin, 25-hydroxyvitamin D, parathormone, phosphorus) and instrumental (heart ultrasound examination, ultrasound densitometry) investigations. In patients with chronic heart failure, a violation of the processes of bone remodeling with a predominance of bone resorption against the background of slowed bone tissue formation was revealed. In patients with chronic heart failure, structural and functional changes in bone tissue were revealed, which are manifested by an imbalance of bone remodeling processes with a predominance of bone resorption and slowed bone formation, vitamin D deficiency, and significantly low indices of bone mineral density. Moreover, significantly pronounced changes were revealed in the group of patients who were on basic chronic heart failure therapy and loop diuretics comparing with the same indices in patients with chronic heart disease who received only basic therapy. |
| Tags |
chronic heart failure,mineral density of bone tissue,markers of bone remodeling,vitamin D |
| Bibliography |
- Adamo M, Gardner RS, McDonagh TA, Metra M. The 'Ten Commandments' of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart. 2022; 43(6): 440–441. doi: 10.1093/eurheartj/ehab853.
- Bhatta L, Cepelis A, Vikjord SA, Malmo V, Laugsand LE, Dalen H. et al. Bone mineral density and risk of cardiovascular disease in men and women: the HUNT study. Eur J Epidemiol. 2021; 6(11): 1169–1177. doi:10.1007/s10654-021-00803-y
- Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017; 19(12): 1574–1585. doi: 10.1002/ejhf.813.
- Fang Y, Wang L, Xing W, Qing W, Qian T, Yanbo Yu. et al. Bone mineral density in older patients with chronic heart failure is related to NYHA classification: a retrospective study. Eur Geriatr Med. 2018; 9(2):183–189. doi:10.1007/s41999-018-0027-5
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab. 2011; 96(7):1911–1930. doi:10.1210/jc.2011-0385
- Kadam UT, Roberts I, White S, Bednall R, Khunti K, Nilsson PM, Lawson CA. Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy. J Clin Epidemiol. 2019; 106: 98–107. doi: 10.1016/j.jclinepi.2018.10.014.
- Paik JM, Rosen HN, Gordon CM, Curhan GC. Diuretic Use and Risk of Vertebral Fracture in Women. Am J Med. 2016; 129(12): 1299–1306. doi: 10.1016/j.amjmed.2016.07.013.
- Špinar J, Špinarová L, Vítovec J. Pathophysiology, causes and epidemiology of chronic heart failure. Vnitr Lek. 2018; 64(9): 834–838.
- Shaposhnyk OA, Prykhodko NP, Savchenko LV, Shevchenko TI, Sorokina SI, Yakymyshyna LI, et al. Clinical and diagnostic aspects of managing patients with valvular heart disease. World of medicine and biology. 2022; 80(2): 178–183. http://dx.doi.org/10.26724/2079-8334-2022-2-80-178-183
- Shevroja E, Cafarelli FP, Guglielmi G, Hans D. DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine. 2021; 74(1): 20–28. doi: 10.1007/s12020-021-02806-x.
- Velliou M, Sanidas E, Zografou A, Papadopoulos D, Dalianis N, Barbetseas J. Antihypertensive Drugs and Risk of Bone Fractures. Drugs Aging. 2022;39(7):551–557. doi:10.1007/s40266-022-00955-w
- Voronkov LH, Berezin OE, Zharinov OI. Comorbidity in chronic heart failure. Recommendations of the All-Ukrainian Association of Cardiologists of Ukraine and the All-Ukrainian Association of Heart Failure Specialists. Heart failure. Klinichna praktyka. No. Vyd. Kyiv „ART STUDIIa DRUKU“, 2020; (2): 54–57
- Xiao F, Qu X, Zhai Z, Jiang C, Li H, Liu X, Ouyang Z, Gu D. Association between loop diuretic use and fracture risk. Osteoporos Int. 2015; 26(2):775–784. doi: 10.1007/s00198-014-2979-8.
- Xing W, Lv X, Gao W, Wang J, Yang Z, Wang S. et al. Bone mineral density in patients with chronic heart failure: a meta-analysis. Clin Interv Aging. 2018; 13: 343-353. doi: 10.2147/CIA.S154356.
- Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P. et al. Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021; 8(2):1007–1017. doi:10.1002/ehf2.13255
|
| Publication of the article |
«World of Medicine and Biology» №3(85), 2023 year, 091-096 pages, index UDK 616.71-007.234-06:616.12-008.46 |
| DOI |
10.26724/2079-8334-2023-3-85-91-96 |
